Der endokrinologische Notfall

[1]  N. Amso,et al.  Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome , 2017 .

[2]  F. Broekmans,et al.  GnRH antagonists are safer than agonists: an update of a Cochrane review. , 2011, Human reproduction update.

[3]  M. Aboulghar,et al.  Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. , 2011, The Cochrane database of systematic reviews.

[4]  L. Ramos,et al.  Does the outcome of ICSI in cases of obstructive azoospermia depend on the origin of the retrieved spermatozoa or the cause of obstruction? A comparative analysis. , 2010, Fertility and sterility.

[5]  C. Simón,et al.  Physiology and pathology of ovarian hyperstimulation syndrome. , 2010, Seminars in reproductive medicine.

[6]  Evangelos Papanikolaou1,et al.  Identification of the High-Risk Patient for Ovarian Hyperstimulation Syndrome , 2010, Seminars in reproductive medicine.

[7]  M. Aboulghar,et al.  Treatment of Ovarian Hyperstimulation Syndrome , 2010, Seminars in reproductive medicine.

[8]  E. Papanikolaou,et al.  Preventing ovarian hyperstimulation syndrome: guidance for the clinician. , 2010, Fertility and sterility.

[9]  Takumi Nakamura,et al.  A man with hypogonadotropic hypogonadism successfully treated with nasal administration of the low-dose gonadotropin-releasing hormone analog buserelin. , 2009, Fertility and sterility.

[10]  C. Coddington,et al.  Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. , 2009, Fertility and sterility.

[11]  D. Goulis,et al.  Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. , 2008, Fertility and sterility.

[12]  Joseph McDonnell,et al.  Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization , 2007, Reproductive biology and endocrinology : RB&E.

[13]  M. Kaufmann,et al.  Von der Pathophysiologie und Prävention des ovariellen Überstimulationssyndroms (OHSS) bis zur stadiengerechten Therapie , 2002 .

[14]  K. Tschaikowsky,et al.  The detrimental role of colloidal volume substitutes in severe ovarian hyperstimulation syndrome: a case report. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[15]  N. Vlahos,et al.  The ovarian hyperstimulation syndrome. , 2000, Fertility and sterility.

[16]  J. Grudzinskas,et al.  Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. , 1999, Human reproduction.

[17]  E. Levin,et al.  Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. , 1998, The Journal of clinical investigation.

[18]  J. Schenker,et al.  The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. , 1997, Human reproduction.

[19]  M. Breckwoldt,et al.  Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. , 1995, The Journal of clinical endocrinology and metabolism.

[20]  D. Seifer,et al.  Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. , 1994, Human reproduction.

[21]  L. Wildt,et al.  Endocrinology: von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome , 1993 .

[22]  V. Wiwanitkit,et al.  Ovarian hyperstimulation syndrome , 1991, The Lancet.

[23]  A. Golan,et al.  Ovarian hyperstimulation syndrome: an update review. , 1989 .

[24]  L. Wildt,et al.  Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. , 1987, Fertility and sterility.

[25]  M. Schwartz,et al.  Goldfish brain extract induces aggregation of acetylcholine receptors on cultured myotubes: Increased activity following optic nerve axotomy , 1981, Neuroscience Letters.

[26]  Schenker Jg,et al.  Ovarian hyperstimulation syndrome. , 1975, Obstetrics and gynecology.

[27]  A. Golan,et al.  Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. , 1990, Fertility and sterility.